Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: Role of p53, NF-Y, and p38 mitogen-activated protein kinase

Molecular and Cellular Biology

Volumn 28, Issue 15, 2008, Pages 4665-4674

  Lecona, E ^a   Barrasa, J I ^a   Olmo, N ^a   Llorente, B ^a   Turnay, J ^a   Lizarbe, M A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CCAAT BINDING FACTOR; LIPOCORTIN 1; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR FACTOR Y; PROTEIN P53;

ANNEXIN A1 GENE; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; COLON; COLON ADENOCARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; UPREGULATION;

ADENOCARCINOMA; ANNEXIN A1; BASE SEQUENCE; BINDING SITES; BLOTTING, WESTERN; BUTYRATES; CCAAT-BINDING FACTOR; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; COLONIC NEOPLASMS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXAMIC ACIDS; MOLECULAR SEQUENCE DATA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 47949131755     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00650-07     Document Type: Article

References (50)

1. Bai, X. F., X. G. Ni, P. Zhao, S. M. Liu, H. X. Wang, B. Guo, L. P. Zhou, F. Liu, J. S. Zhang, K. Wang, Y. Q. Xie, Y. F. Shao, and X. H. Zhao. 2004. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J. Gastroenterol. 10:1466-1470.
2. Benatti, P., V. Basile, D. Merico, L. I. Fantoni, E. Tagliafico, and C. Imbriano. 2008. A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response. Nucleic Acids Res. 36:1415-1428.
3. Bevilacqua, M. A., M. C. Faniello, B. Iovine, T. Russo, F. Cimino, and F. Costanzo. 2002. Transcription factor NF-Y regulates differentiation of CaCo-2 cells. Arch. Biochem. Biophys. 407:39-44.
4. Cartharius, K., K. Frech, K. Grote, B. Klocke, M. Haltmeier, A. Klingenhoff, M. Frisch, M. Bayerlein, and T. Werner. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933-2942.
5. D'Acquisto, F., A. Merghani, E. Lecona, G. Rosignoli, K. Raza, C. D. Buckley, R. J. Flower, and M. Perretti. 2007. Annexin 1 modulates T-cell activation and differentiation. Blood 109:1095-1102.
6. Daniel, C., O. Schroder, N. Zahn, T. Gaschott, and J. Stein. 2004. p38 MAPK signaling pathway is involved in butyrate-induced vitamin D receptor expression. Biochem. Biophys. Res. Commun. 324:1220-1226.
7. Davie, J. R. 2003. Inhibition of histone dcacetylase activity by butyrate. J. Nutr. 133:2485S-2493S.
8. Djelloul, S., M. E. Forgue-Lafitte, B. Hermelin, M. Mareel, E. Bruyneel, A. Baldi, A. Giordano, E. Chastre, and C. Gespach. 1997. Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco-2 cells. Status of the pRb1 and pRb2 tumor suppressor gene products. FEBS Lett. 406:234-242.
9. Donnelly, S. R., and S. E. Moss. 1998. Functional analysis of the human annexin I and VI gene promoters. Biochem. J. 332:681-687.
10. Gerke, V., C. E. Creutz, and S. E. Moss. 2005. Annexins: linking Ca2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6:449-461.
11. Gerke, V., and S. E. Moss. 2002. Annexins: from structure to function. Physiol. Rev. 82:331-371.
12. Gui, C. Y., L. Ngo, W. S. Xu, V. M. Richon, and P. A. Marks. 2004. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc. Natl. Acad. Sci. USA 101:1241-1246.
13. Guzmán-Aránguez, A., N. Olmo, J. Turnay, E. Lecona, P. Perez-Ramos, I. López de Silanes, and M. A. Lizarbe. 2005. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J. Cell Biochem. 94:178-193.
14. -/- mouse. FASEB J. 17:253-255.
15. Hirose, T., Y. Sowa, S. Takahashi, S. Saito, C. Yasuda, N. Shindo, K. Furuichi, and T. Sakai. 2003. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. Oncogene 22:7762-7773.
16. Hoh, J., S. Jin, T. Parrado, J. Edington, A. J. Levine, and J. Ott. 2002. The p53MH algorithm and its application in detecting p53-responsive genes. Proc. Natl. Acad. Sci. USA 99:8467-8472.
17. Huang, W., S. Zhao, S. Ammanamanchi, M. Brattain, K. Venkatasubbarao, and J. W. Freeman. 2005. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. J. Biol. Chem. 280:10047-10054.
18. 2/M promoters. Mol. Cell. Biol. 25:3737-3751.
19. Isacke, C. M., R. A. Lindberg, and T. Hunter. 1989. Synthesis of p36 and p35 is increased when U-937 cells differentiate in culture but expression is not inducible by glucocorticoids. Mol. Cell. Biol. 9:232-240.
20. Jin, S., and K. W. Scotto. 1998. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 18:4377-4384.
21. Kim, S. W., H. J. Rhee, J. Ko, Y. J. Kim, H. G. Kim, J. M. Yang, E. C. Choi, and D. S. Na. 2001. Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site. J. Biol. Chem. 276:15712-15719.
22. Lopez-Conejo, T., N. Olmo, J. Turnay, J. Navarro, and A. Lizarbe. 1996. Characterization of tumorigenic sub-lines from a poorly tumorigenic human colon-adenocarcinoma cell line. Int. J. Cancer 67:668-675.
23. López de Silanes, I., N. Olmo, J. Turnay, G. González de Buitrago, P. Pérez-Ramos, A. Guzmán-Aránguez, M. García-Díez, E. Lecona, M. Gorospe, and M. A. Lizarbe. 2004. Acquisition of resistance to butyrate enhances survival after stress and induces malignancy of human colon carcinoma cells. Cancer Res. 64:4593-4600.
24. Manni, I., G. Mazzaro, A. Gurtner, R. Mantovani, U. Haugwitz, K. Krause, K. Engeland, A. Sacchi, S. Soddu, and G. Piaggio. 2001. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J. Biol. Chem. 276:5570-5576.
25. Marutani, M., H. Tonoki, M. Tada, M. Takahashi, H. Kashiwazaki, Y. Hida, J. Hamada, M. Asaka, and T. Moriuchi. 1999. Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme. Cancer Res. 59:4765-4769.
26. McMillan, L., S. K. Butcher, J. Pongracz, and J. M. Lord. 2003. Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases. Br J. Cancer 88:748-753.
27. Minucci, S., and P. G. Pelicci. 2006. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 6:38-51.
28. Nakano, K., T. Mizuno, Y. Sowa, T. Orita, T. Yoshino, Y. Okuyama, T. Fujita, N. Ohtani-Fujita, Y. Matsukawa, T. Tokino, H. Yamagishi, T. Oka, H. Nomura, and T. Sakai. 1997. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem. 272:22199-22206.
29. Navarro, J. M., N. Olmo, J. Turnay, M. T. López-Conejo, and M. A. Lizarbe. 1997. Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5′-nucleotidase activity. Eur. J. Clin. Investig. 27:620-628.
30. Olmo, N., J. Turnay, E. Lecona, M. Garcia-Diez, B. Llorente, A. Santiago-Gomez, and M. A. Lizarbe. 2007. Acquisition of resistance to butyrate induces resistance to luminal components and other types of stress in human colon adenocarcinoma cells. Toxicol. In Vitro 21:254-261.
31. Omer, S., D. Meredith, J. F. Morris, and H. C. Christian. 2006. Evidence for the role of adenosine 5′-triphosphate-binding cassette (ABC)-A1 in the externalization of annexin 1 from pituitary folliculostellate cells and ABCA1-transfected cell models. Endocrinology 147:3219-3227.
32. Parente, L., and E. Solito. 2004. Annexin 1: more than an anti-phospholipase protein. Inflamm. Res. 53:125-132.
33. Patton, K. T., H. M. Chen, L. Joseph, and X. J. Yang. 2005. Decreased annexin 1 expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology 47:597-601.
34. Perretti, M., and F. N. Gavins. 2003. Annexin 1: an endogenous anti-inflammatory protein. News Physiol. Sci. 18:60-64.
35. Petrella, A., C. W. D'Acunto, M. Rodriquez, M. Festa, A. Tosco, I. Bruno, S. Terracciano, M. Taddei, L. G. Paloma, and L. Parente. 2008. Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: Role of Annexin A1. Eur. J. Cancer 44:740-749.
36. Petrella, A., M. Festa, S. F. Ercolino, M. Zerilli, G. Stassi, E. Solito, and L. Parente. 2006. Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol. Ther. 5:643-647.
37. Rodrigo, J. P., J. M. Garcia-Pedrero, M. V. Gonzalez, M. P. Fernandez, C. Suarez, and A. Herrero. 2004. Expression of amiexin A1 in normal and chronically inflamed nasal mucosa. Arch. Otolaryngol. Head Neck Surg. 130:211-215.
38. Sandoval, J., J. L. Rodríguez, G. Tur, G. Serviddio, J. Pereda, A. Boukaba, J. Sastre, L. Torres, L. Franco, and G. López-Rodas. 2004. RNAPol-ChIP: a novel application of chromatin immunoprecipitation to the analysis of real-time gene transcription. Nucleic Acids Res. 32:e88.
39. Scheppach, W., and F. Weiler. 2004. The butyrate story: old wine in new bottles? Curr. Opin. Clin. Nutr. Metab. Care 7:563-567.
40. Shen, D., F. Nooraie, Y. Elshimali, V. Lonsberry, J. He, S. Bose, D. Chia, D. Seligson, H. R. Chang, and L. Goodglick. 2006. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum. Pathol. 37:1583-1591.
41. Solito, E., C. de Coupade, L. Parente, R. J. Flower, and F. Russo-Marie. 1998. Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ. 9:327-336.
42. Solito, E., C. de Coupade, L. Parente, R. J. Flower, and F. Russo-Marie. 1998. IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine 10:514-521.
43. Tabe, Y., L. Jin, R. Contractor, D. Gold, P. Ruvolo, S. Radke, Y. Xu, Y. Tsutusmi-Ishii, K. Miyake, N. Miyake, S. Kondo, A. Ohsaka, I. Nagaoka, M. Andreeff, and M. Konopleva. 2007. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death Differ. 14:1443-1456.
44. Turnay, J., N. Olmo, J. G. Gavilanes, J. Benítez, and M. A. Lizarbe. 1990. Establishment and characterization of a new human colon adenocarcinoma cell line: BCS-TC2. Cytotechnology 3:75-88.
45. Vishwanatha, J. K., E. Salazar, and V. K. Gopalakrishnan. 2004. Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer 4:8.
46. Wang, K. L., T. T. Wu, E. Resctkova, H. Wang, A. M. Correa, W. L. Hofstetter, S. G. Swisher, J. A. Ajani, A. Rashid, S. R. Hamilton, and C. T. Albarracin. 2006. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin. Cancer Res. 12:4598-4604.
47. Wu, C. M., Y. S. Lee, T. H. Wang, L. Y. Lee, W. H. Kong, E. S. Chen, M. L. Wei, Y. Liang, and T. L. Hwang. 2006. Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray. Oncol. Rep. 15:57-64.
48. Yonezawa, T., Y. Kobayashi, and Y. Obara. 2007. Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. Cell. Signal. 19:185-193.
49. Yun, J., H. D. Chae, T. S. Choi, E. H. Kim, Y. J. Bang, J. Chung, K. S. Choi, R. Mantovani, and D. Y. Shin. 2003. Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway. J. Biol. Chem. 278:36966-36972.
50. Waf1/Cip1. Mol. Cell. Biol. 26:2782-2790.